Singapore, Singapore--(Newsfile Corp. - February 11, 2014) - Zecotek Photonics Inc.
(TSXV: ZMS) (Frankfurt: W1I.F), a developer of leading-edge photonics
technologies for medical, industrial and scientific markets, today announced
that it has retained the services of Waterfront Capital Corporation of West
Vancouver to provide business advisory and/or investor relations services for
the Company, subject to TSX Venture Exchange approval. The contract is effective
immediately and will continue on a month to month basis.
Waterfront Capital will provide a business advisory and/or
investor relations services in order to increase investor awareness and
introduce the Company to private investors, institutions, analysts, brokers,
fund managers, and other key influencers in the North American and international
investment community at large.
Under the term of the agreement, Zecotek will pay Waterfront
Capital $10,000 per month and grant options to purchase 200,000 common shares at
a price of $0.82 per share for five years. In accordance with exchange
regulations, the options will vest over a period of 12 months.
About Waterfront Capital
Waterfront Capital offers a full range of financial and
communications services to growth companies in leading industry sectors.
Waterfront Capital often serves as a company's strategic partner through the
entire corporate "life-cycle", providing independent expertise and business
advisory services in connection with venture capital markets, investor
relations, initial public offerings and secondary financings, mergers and
acquisitions, public market administration, as well as media and marketing
advice. Waterfront Capital's professionals have extensive financing and
operating experience and assist promising public and private companies that
require infusions of capital, management and restructuring to realize the value
and potential of their underlying business.
About Zecotek
Zecotek Photonics Inc (TSXV: ZMS) (Frankfurt: W1I) is a
photonics technology company developing high-performance scintillation crystals,
photo detectors, positron emission tomography scanning technologies, 3D
auto-stereoscopic displays, and lasers for applications in medical, high-tech
and industrial sectors. Founded in 2004, Zecotek operates three divisions:
Imaging Systems, Laser Systems and 3D Display Systems with labs located in
Canada, Korea, Russia, Singapore and U.S.A. The management team is focused on
building shareholder value by commercializing over 50 patented and patent
pending novel photonic technologies directly and through strategic alliances and
joint ventures with leading industry partners such as the European Organization
for Nuclear Research (Switzerland), Beijing Opto-Electronics Technology Co. Ltd.
(China), NuCare Medical Systems (South Korea), and National NanoFab Center
(South Korea). For more information visit www.zecotek.com, follow @zecotek on Twitter and "like"
us in Facebook at www.facebook.com/zecotek.
This press release may contain forward-looking statements that
are based on management's expectations, estimates, projections and assumptions.
These statements are not guarantees of future performance and involve certain
risks and uncertainties, which are difficult to predict. Therefore, actual
future results and trends may differ materially from what may have been stated.
For Additional Information Please Contact:
Zecotek Photonics Inc.
Michael Minder
T: (604) 783-8291
ir@zecotek.com
Neither the TSX Venture Exchange nor its Regulation Service
Provider (as that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of the content of this news
release. If you would like to receive news from Zecotek in the future please
visit the corporate website at www.zecotek.com.
copyright (c) newsfile corp. 2014. all rights reserved